Antimicrobial resistance among WHO priority carbapenem-resistant pathogens in Indonesia: a bibliometric analysis and scoping review
Abstract
Purpose: Carbapenem-resistant organisms (CROs) designated as "Critical Priority" on the 2024 Bacterial Priority Pathogens List (BPPL) pose a major public health risk in Indonesia. However, the country's research focus and the precise epidemiological burden of these pathogens remain poorly understood.
Methods: This study combined bibliometric analysis with a scoping review. Metadata were extracted from Scopus and PubMed (February 2026) using targeted Boolean queries. Bibliometric mapping was conducted in VOSviewer (v1.6.20), and the scoping review followed PRISMA-ScR guidelines and the PECO framework. The analysis focused on carbapenem-resistant Acinetobacter baumannii (CRAB), Pseudomonas aeruginosa (CRPA), and Enterobacterales (CRE) in Indonesian clinical settings.
Results: Eleven studies were included from 31 identified records. Research output increased after 2019, with activity primarily centered in Jakarta and Surabaya, and a noticeable shift from phenotypic to molecular characterization after 2020. Key findings include a 50.5% resistance rate in CRAB and high rates of carbapenemase gene carriage in CRPA (69.7%) and K. pneumoniae (96.0%), with blaNDM identified as the predominant genotype. Clinically, CRAB infections were associated with significantly longer ICU stays and more than twice the hospitalization costs compared with susceptible cases.
Conclusion: Carbapenem resistance among WHO critical priority pathogens in Indonesia is significant and genetically diverse, imposing a serious clinical and economic burden. Current research is largely concentrated in Java. To address this crisis, expanded national surveillance, decentralized research capabilities, and stronger infection prevention and control (IPC) programs are needed nationwide.
References
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infectious Diseases. 2018; 18(3):318–27.
Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, et al. The WHO bacterial priority pathogens list 2024: a prioritization study to guide research, development, and public health strategies against antimicrobial resistance. The Lancet Infectious Diseases. 2025;25(9):1033–43.
Dharmayanti NLPI, Kusala MKJ, Nuradji H, Nurjanah D. Antimicrobial resistance in Indonesia: a comprehensive one health analysis and strategic roadmap for mitigation. International Journal of One Health. 2025;11(1):34–53.
Siahaan S, Herman MJ, Fitri N. Antimicrobial resistance situation in Indonesia: a challenge of multisector and global coordination. Journal of Tropical Medicine. 2022;2022(1):2783300.
Gidey K, Gidey MT, Hailu BY, Gebreamlak ZB, Niriayo YL. Clinical and economic burden of healthcare-associated infections: A prospective cohort study. PLoS ONE. 2023;18(2):e0282141.
Institute for Health Metrics and Evaluation (IHME). The burden of antimicrobial resistance (AMR) in Indonesia. Seattle: University of Washington; 2022. Available from: [Website]
Parathon H, Kuntaman K, Widiastoety TH, Muliawan BT, Karuniawati A, Qibtiyah M, et al. Progress towards antimicrobial resistance contain- ment and control on Indonesia. BMJ. 2017;358: j3808.
Perhimpunan Dokter Spesialis Mikrobiologi Klinik Indonesia (PAMKI). Buku SINAR-PAMKI 2025: Data resistensi antibiotik Indonesia tahun 2024. Jakarta: PAMKI; 2025. Available from: [Website]
Chowdhury F, Bhuiya S, Abdul Aleem M, Shuvo TA, Mamun GMdS, Kumar Ghosh P, et al. Decade-long trends in antibiotic prescriptions according to WHO AWaRe classification among patients with severe acute respiratory infection at tertiary hospitals in Bangladesh (2011–2020). Antibiotics. 2025;14(2):199.
Limato R, Nelwan EJ, Mudia M, Alamanda M, Manurung ER, Mauleti IY, et al. Perceptions, views, and practices regarding antibiotic prescribing and stewardship among hospital physicians in Jakarta, Indonesia: a questionnaire-based survey. BMJ Open. 2022;12(5):e054768.
Religioni U, Barrios-Rodríguez R, Requena P, Borowska M, Ostrowski J. Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina. 2025; 61(1):153.
Kadariswantiningsih IN, Rampengan DD, Ramadhan RN, Idrisova A, Idrisov B, Empitu MA. Antibiotic resistance in Indonesia: A systematic review and meta‐analysis of extended-spectrum beta-lacta- mase-producing bacteria (2008–2024). Tropical Medicine and International Health. 2025; 30(4):246–59.
Sugianli AK, Ginting F, Parwati I, De Jong MD, Van Leth F, Schultsz C. Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review. JAC-Antimicrobial Resistance. 2021;3(1):dlab003.
Rosyid AN, Endraswari PD, Setiawan F, Puspitasari Y, Asmarawati TP, Rachman BE, et al. Demystify carbapenem-resistant Acinetobacter baumannii pneumonia burden: 2-year cohort study. Annals of African Medicine. 2025;24(4):909–15.
Karuniawati A, Saharman YR, Lestari DC. Detection of carbapenemase encoding genes in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii isolated from patients at intensive care unit of Cipto Mangunkusumo Hospital in 2011. Acta Medica Indonesiana. 2013; 45(2):101–6.
Saharman YR, Pelegrin AC, Karuniawati A, Sedono R, Aditianingsih D, Goessens WHF, et al. Epidemiology and characterisation of carbapenem- non-susceptible Pseudomonas aeruginosa in a large intensive care unit in Jakarta, Indonesia. International Journal of Antimicrobial Agents. 2019; 54(5):655–60.
Saharman YR, Karuniawati A, Sedono R, Aditianingsih D, Goessens WHF, Klaassen CHW, et al. Clinical impact of endemic NDM-producing Klebsiella pneumoniae in intensive care units of the national referral hospital in Jakarta, Indonesia. Antimicrobial Resistance and Infection Control. 2020;9(1):61.
Endraputra PN, Kuntaman K, Wasito EB, Shirakawa T, Raharjo D, Setyarini W. Profile variation of bla genes among non-lactose fermenting Gram-negative bacilli between clinical and environmental isolates of Dr. Soetomo Hospital, Surabaya, Indonesia. Biodiversitas: Journal of Biological Diversity. 2021; 22(11).
Inggraini M, Nurfajriah S, Priyanto JA, Ilsan NA. Antimicrobial susceptibility and molecular species identification of clinical carbapenem-resistant bacteria. Biodiversitas: Journal of Biological Diversity. 2021;22(2).
Sumardika IW, Cokro F, Suranadi IW, Pinatih KJP. Multidrug-resistant organism infections correlate with increased mortality in COVID-19 patients: a retrospective, observational cohort study. Bali Journal of Anesthesiology. 2022;6(4):231–4.
Karmila A, Barchia I, Ramandati A, Zhang L. Clinical and bacteriological profile of culture-negative and culture-proven neonatal sepsis in Palembang, Indonesia. The Journal of Infection in Developing Countries. 2022;16(12):1887–96.
Endraswari P, Mertaniasih NM, Setiawan F, Paramita AL. Epidemiology of Escherichia coli as a critical pathogen of bloodstream infection patients in a tertiary referral hospital. Indonesian Journal of Tropical Infectious Disease. 2022;10(3):205–13.
Homenta H, Julyadharma J, Susianti H, Noorhamdani N, Santosaningsih D. Molecular epidemiology of clinical carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex isolates in tertiary care hospitals in Java and Sulawesi Islands, Indonesia. Tropical Medicine and Infectious Disease. 2022;7(10):277.
Arsyad ZS, Pertiwi YD, Ramadhan AR, Syamsuri F, Rasita YD, Tenriesa L, et al. Identification of carbapenemase gene in sinks of the general hospital in Makassar City, Indonesia. Archives of Clinical Infectious Diseases. 2025;20(4):e161604.
Nowak P, Paluchowska P. Acinetobacter baumannii: biology and drug resistance — role of carbapenemases. Folia Histochemica et Cytobiologica. 2016;54(2), 61–74.
Oliver A, Arca-Suárez J, Gomis-Font MA, González-Pinto L, López-Causapé C. Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa. Clinical Microbiology and Infection. 2025;31(11):1790–6.
Türkyılmaz O, Darcan C. Molecular basis of ampicillin resistance: combinatorial mechanisms and future strategies. World Journal of Microbiology and Biotechnology. 2026;42(2):79.
Weingarten RA, Johnson RC, Conlan S, Ramsburg AM, Dekker JP, Lau AF, et al. Genomic analysis of hospital plumbing reveals diverse reservoir of bacterial plasmids conferring carbapenem resistance. Bonomo RA, Editor. mBio. 2018;9(1): e02011-17.
Kuntaman K, Shigemura K, Osawa K, Kitagawa K, Sato K, Yamada N, et al. Occurrence and characterization of carbapenem‐resistant Gram‐ negative bacilli: A collaborative study of antibiotic‐ resistant bacteria between Indonesia and Japan. International Journal of Urology. 2018;25(11):966 –72.
Putri ND, Dickson BF, Adrizain R, Kartina L, Baker J, Sukarja D, et al. Epidemiology of sepsis in hospitalized neonates in Indonesia: high burden of multidrug-resistant infections reveals poor coverage provided by recommended antibiotic regimens. BMJ Global Health. 2025;10(4):e016272.
Wen SCH, Ezure Y, Rolley L, Spurling G, Lau CL, Riaz S, et al. Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis. PLoS Medicine. 2021;18(9): e1003787.
Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infection. 2020;26(12):1622–9.
Gordon AEK, Mathers AJ, Cheong EYL, Gottlieb T, Kotay S, Walker AS, et al. The hospital water environment as a reservoir for carbapenem- resistant organisms causing hospital-acquired infections—a systematic review of the literature. Clinical Infectious Disease. 2017;64 (10):1435–44.
Fouz N, Pangesti KNA, Yasir M, Al-Malki AL, Azhar EI, Hill-Cawthorne GA, et al. The contribution of wastewater to the transmission of antimicrobial resistance in the environment: implications of mass gathering settings. Tropical Medicine and Infectious Disease. 2020;5(1):33.
Copyright (c) 2026 Anwar Rovik, Dian Asti Umaroh, Ahmad Ikhsanudin, Dion Saputra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
